Posters Presented at DDW 2022 Demonstrate G-Tech System Motility Measurements Correlate with Antroduodenal Manometry Measurements and Can be Used to Characterize Colon Motility Alteration

MOUNTAIN VIEW, Calif., May 26, 2022G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that two posters were presented at Digestive Disease Week Conference held in San Diego in from May 21 through May 24.

The first poster, entitled Wireless non-invasive patches detect phase III of the migrating motor complex in response to octreotide administration, reported on a study performed in humans by researchers from the Children’s Hospital of Philadelphia and GTech.  The key finding of the study was that the G-Tech patches detected spectral peaks in myoelectric activity at the same frequencies detected by simultaneous antroduodenal manometry after octreotide administration. These frequencies (11-12 cpm) have previously been associated with small bowel activity.

The second poster, entitled Development and Characterization of an opioid-induced constipation (OIC) model in swine: use of G-Tech wireless non-invasive patches to monitor colonic myoelectrical activity (CMA), reported on a study performed by researchers from UCLA and G-Tech. The study described the development of a valid model of OIC in pigs. The patches demonstrated sensitivity to detect effects of loperamide on the porcine CMA and showed potential to help characterize colon motility alteration as in constipation.

These posters are only the most recent in a series of over 20 posters, multiple invited talks and five peer-reviewed journal articles that demonstrate validity of the underlying measurement of GI motility and its potential for broad, game-changing clinical application.

“We’re extremely fortunate to collaborate with such esteemed partners in the academic community to help move motility science forward,” said Steve Axelrod, CEO of G-Tech.

The G-Tech WPS is a tool that provides gastric and intestinal myoelectrical activity measurements to be used at the discretion of the Physician or Clinical researcher to aid in the diagnosis and evaluation of gastrointestinal disorders and dysfunctions.

 About G-Tech Medical

G-Tech Medical, Inc. is an early-stage medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

#   #   #

Media Contact

Rob Kirby

G-Tech Medical

rob@gtechmedical.com

Two Posters to be Presented at Digestive Disease Week 2022

MOUNTAIN VIEW, Calif., March 15, 2022G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that two posters have been accepted for presentation at the upcoming Digestive Disease Week Conference to be held in San Diego in from May 21 through May 24.

The first poster, entitled Wireless non-invasive patches detect phase III of the migrating motor complex in response to octreotide administration, reports on a study performed by researchers from the Children’s Hospital of Philadelphia and G-Tech. The second poster, entitled Development and Characterization of an opioid-induced constipation (OIC) model in swine: use of G-Tech wireless non-invasive patches to monitor colonic myoelectrical activity (CMA), reports on a study performed by researchers from UCLA and G-Tech.

“When these posters are presented, over 25 scientific presentations and posters and 4 clinical articles will have been published on the G-Tech motility solution,” said Steve Axelrod, CEO of G-Tech. “We’re extremely fortunate to collaborate with such motivated partners in the academic community to help move motility science forward.”

The G-Tech WPS is a tool that provides gastric and intestinal myoelectrical activity measurements to be used at the discretion of the Physician or Clinical researcher to aid in the diagnosis and evaluation of gastrointestinal disorders and dysfunctions.

 

About G-Tech Medical

G-Tech Medical, Inc. is an early-stage medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

 

#   #   #

 

Media Contact

Rob Kirby

G-Tech Medical

rob@gtechmedical.com

 

G-Tech Medical Receives FDA Clearance for its Gastrointestinal Motility Monitoring System

MOUNTAIN VIEW, Calif., January 13, 2022G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Wireless Patch System (WPS) for non-invasive myoelectric activity measurement.

The G-Tech WPS is a tool that provides gastric and intestinal myoelectrical activity measurements to be used at the discretion of the Physician or Clinical researcher to aid in the diagnosis and evaluation of gastrointestinal disorders.

“We are excited to receive our first regulatory clearance,” said Steve Axelrod, CEO of G-Tech. “This is a key achievement in support of our ultimate goal of providing a motility solution that localizes the sources and identifies the nature of GI disorders.”

Gastrointestinal (GI) motility is the underlying factor in a wide range of disorders and dysfunction experienced by tens of millions in the U.S. GI disorders include inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGID’s).1 GI dysfunctions are also prevalent during recovery from abdominal surgery which can lead to post-operative ileus (POI).2

Current motility technologies are typically limited in scope, invasive and only sample for a brief time period in a non-physiological setting, such as a hospital or physician office. The G-Tech product, in contrast, measures myoelectrical signals from the stomach, small intestines and colon over multiple days non-invasively in a variety of settings.

G-Tech will continue to prioritize investment in clinical trials in the near term.

“It’s all about the data. Developing a large, proprietary data set which we can mine and analyze to drive new learnings, and correlate motility with specific GI issues, is key for us,” said Axelrod. “We truly believe our ‘EKG for the Gut’ will become a standard of care in gastroenterology over time. Growing our patient motility database is the shortest path to that future.”

  1. Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019 Jan;156(1):254-272.e11. doi: 10.1053/j.gastro.2018.08.063. Epub 2018 Oct 10. Erratum in: Gastroenterology. 2019 May;156(6):1936. PMID: 30315778; PMCID: PMC6689327.
  1. Nachlas, MARVIN M., M. Tewfic Younis, C. Pio Roda, and JOSEPH J. Wityk. “Gastrointestinal motility studies as a guide to postoperative management.” Annals of surgery 175, no. 4 (1972): 510. 

About G-Tech Medical

G-Tech Medical, Inc. is an early-stage medical device company dedicated to developing low-cost, non-invasive gastrointestinal monitoring solutions for patients with chronic GI disorders. G-Tech’s wearable wireless patch will provide patient-specific motility data to physicians, helping them assess underlying causes of GI disorders and develop targeted therapies. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

#   #   #

Media Contact

Rob Kirby

G-Tech Medical

rob@gtechmedical.com

 

 

G-Tech Medical Appoints Rob Kirby as Vice President of Strategy and Business Development

Mountain View, Calif., November 5, 2021 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that Rob Kirby has been hired as Vice President of Strategy and Business Development.

“We are very excited that Rob has joined our company,” said Steve Axelrod, CEO of G-Tech. “As a startup we know that every hire is critical, and that adding versatile performers is especially important. Rob has demonstrated a rare ability in his career to succeed in many different roles. It’s also already clear that he will have a strong cultural fit with our small but growing team.”

Rob has worked for over 20 years in medical device startup companies. His breadth of experience includes strategic planning, business development, marketing and cross-functional program leadership. He has held leadership roles at Xoft, TAE Life Sciences and other device companies. Rob holds a BS degree in Mechanical Engineering from UC Davis and an MBA with a strategic planning emphasis from UC Riverside.

“I’m absolutely thrilled to join G-Tech,” said Kirby. “I have known Steve for many years. I’ve been keeping a close eye on G-Tech’s progress from the days when the product was just an idea in Steve’s head, through these past several years of product development and clinical trials. It is truly remarkable how far such a small team has come in such a short amount of time. The chance to join the company at this pivotal time and play a role in commercializing this technology is a rare opportunity.”

G-Tech has developed a wireless wearable patch that measures GI motility of the stomach, small intestines and colon non-invasively over multiple days. Over 600 tests have been run under IRB approvals, resulting in 4 peer reviewed publications and numerous conference posters.

“Until now our team has focused on building the technology platform and confirming its clinical utility,” added Axelrod. “Rob’s hire is significant for us because it marks a turning point for G-Tech. We have succeeded in developing the GI motility tool that we set out to create. Now we can refocus our energy on building out the business so that our GI motility solution will positively impact patient’s lives and will potentially become a standard of care.”

The G-Tech patch system is not currently available for sale and does not have regulatory clearance or approval.

 

About G-Tech Medical

G-Tech Medical, Inc. is an early-stage medical device company dedicated to developing low-cost, non-invasive, diagnostic solutions for patients with chronic gastrointestinal disorders. G-Tech’s wearable patch-based “EKG for the Gut” will be used to diagnose underlying causes of GI disorders, allowing physicians to develop targeted therapies, thereby speeding relief to patients and significantly lowering the cost of health care. The company is headquartered at Fogarty Innovation, 2495 Hospital Drive, Suite 300, Mountain View, CA 94040. For further information, please visit www.GTechMedical.com or email info@gtechmedical.com.

 

#   #   #

 

Media Contact

Steve Axelrod

G-Tech Medical

650 269-1479

steve.axelrod@gtechmedical.com

G-Tech Medical Presents at the 2020 Digestive Disease Week

DDW 2020 logoG-Tech Medical will be in Chicago in May at the 2020 Digestive Disease Week with two posters in collaboration with researchers at Stanford University.

The first with findings from an ongoing longitudinal study of patients with Crohn’s disease demonstrates the uniqueness of each patient’s physiological gut print and its reproducibility as captured by G-Tech’s non-invasive patch system. The second abstract presents preliminary findings from a study measuring digestive vagal dysfunction in a patient population with gastroparesis.

G-Tech Medical’s Lindsay Axelrod Presents Her Abstract

Crohn's & Colitis Foundation logoG-Tech Medical’s Lindsay Axelrod presented her abstract with preliminary findings from an ongoing collaborative study with Stanford University supported by the Helmsley Charitable Trust. The study involves using non-invasive wireless electrode patches to read myoelectrical signals from the gut over 3 days in patients with Crohn’s disease. Forty patients presenting in flare, and 30 in remission will be tested at t=0,1,3 and 6 months.  

Steve Axelrod, PhD, Invited to Talk at the IEEE-EMBS Santa Clara Valley Chapter

IEEE logoSteve Axelrod, PhD, CEO, G-Tech Medical will give an invited talk at the IEEE-EMBS Santa Clara Valley chapter presenting early results from proof of concept clinical trials with G-Tech Medical’s “EKG for the Gut”.

Stanford Research Present G-Tech

DDW 2016 logoStanford researchers presented early findings with the use of G-Tech patch system to understand postoperative recovery patterns at DDW17.

image of Stanford paper